அறிவியல் குழு ஆஃப் தி பலகை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அறிவியல் குழு ஆஃப் தி பலகை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அறிவியல் குழு ஆஃப் தி பலகை Today - Breaking & Trending Today

UCB Full Year Report 2020: UCB - sustaining growth, now and into the future (3)


CET- Comunicado -
;ultimaHoraHtml +=
+ json.lead + ;}ultimaHoraHtml += ;
document.getElementById( urgente ).innerHTML = ultimaHoraHtml;
}
}
});
· The appointment of Mrs. Fiona du Monceau as Director. If elected by the AGM 2021, she will become Vice Chair of the Board in replacement of Pierre Gurdjian, who will stay in the Board as independent Director for the remainder of his mandate. Fiona du Monceau is a representative of the Reference Shareholder and does not qualify as independent Director in accordance with the criteria of the 2020 Code.
· The appointment of Mr. Jonathan Peacock as independent Director. Jonathan Peacock meets all criteria of the 2020 Code and the Board to qualify as independent Director. If he is elected by the AGM 2021, Jonathan Peacock will become the Chair of the Audit Committee in replacement of Albrecht De Graeve. ....

Bruxelles Capitale , Pierre Gurdjian , Viviane Monges , Alice Dautry , Susan Gasser , Mazars Bedrijfsrevisoren , Waterhouse Cooper Pw , Jonathan Peacock , Assembly On , Sustainability Governance Committee , Scientific Committee Of The Board , Audit Committee , Vice Chair , Preference Shareholder , Albrecht De Graeve , General Meeting , Professor Susan Gasser , General Assembly , Professor Alice Dautry , Prof Susan Gasser , Prof Gasser , Scientific Committee , Price Waterhouse Cooper , External Sustainability Advisory Board , United Nations , Global Compact ,

UCB announces changes on Board of Directors | PressReleasePoint


About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 7 500 people operating in ~ 40 countries, the company generated revenue of € 4.9 billion in 2019. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB news
Forward looking statements – UCB
This press release contains forward-looking statements including, without limitation, statements containing the words “believes”, “anticipates”, “expects”, “intends”, “plans”, “seeks”, “estimates”, “may”, “will”, “continue” and similar expressions. These forward-looking statements are based on current plans, estimates and beliefs of management. All statements, other than statements of historical facts, are statements th ....

Bruxelles Capitale , Jean Christophe Tellier , Isabelle Ghellynck , Alice Dautry , Susan Gasser , Laurent Schots , Antje Witte , University Of Basel , Tokyo Institute Of Technology , Scientific Committee Of The Board , Friedrich Miescher Institute For Biomedical Research , Belgian Code Of Companies , University Of Geneva , Corporate Communications , University Of Chicago , University Of Lausanne , Scientific Committee , Professor Susan Gasser , Professor Alice Dautry , Prof Susan Gasser , Belgian Code , Prof Alice , Annual General Meeting , Executive Committee , Tokyo Institute , Friedrich Miescher Institute ,